Pfizer Inc

NYSE: PFE
$26.37
+$0.01 (+0.0%)
Real Time Data Delayed 15 Min.

PFE Articles

These seven big-dividend stocks offer growth if the market continues higher, but also a degree of safety if the AI-driven bubble bursts and market declines and volatility return, as J.P. Morgan warns...
Friday's top analyst upgrades and downgrades included Citizens Financial, Eaton, Freeport-McMoRan, General Mills, Graphic Packaging, Micron Technology, Mosaic, Netflix, Pfizer, Roku, Ross Stores and...
With money market and certificate of deposit rates over 4% and interest rate hikes winding down, it makes sense now for growth and income investors to look at blue chip stocks with big and dependable...
Friday's top analyst upgrades and downgrades included Albemarle, Alcoa, Alphabet, Block, CF Industries, Kraft Heinz, Livent, Mosaic, Norfolk Southern, Pfizer, RingCentral, Roblox, StoneCo, Trade...
Before U.S. markets open on Tuesday, these four companies are scheduled to release quarterly earnings reports.
With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking for growth and income. These seven industry leaders offer solid total return potential in a...
Monday's top analyst upgrades and downgrades included Altria, Block, Coinbase Global, Deere, First Horizon, KB Home, Pfizer, PNC Financial Services, RingCentral, Uber Technologies znd Zoom Video...
Top Wall Street strategists are stressing that value remains the best place to be until the final bottom for the bear market is seen. Here are seven dividend-paying value stocks that should hold up...
The U.S. Treasury Department and the Federal Reserve took decisive steps to prevent the collapse of two banks from turning into a bank run. Equities were showing some positive effects early Monday.
Tuesday's top analyst upgrades and downgrades included Altria, Apple, D.R. Horton, Equitrans Midstream, Fortinet, General Electric, Nextracker, Palo Alto Networks, Pfizer, Silvergate Capital, Tesla...
Warren Buffett's annual letter, Bed Bath & Beyond's latest lease on life and a possible pharma deal worth more than $30 billion.
Wednesday's top analyst upgrades and downgrades included Alcoa, Cloudflare, Foot Locker, Fortinet, Lockheed Martin, On Semiconductor, Ovintiv, Pfizer, Take-Two Interactive Software, Tyson Foods and...
Five companies, including three Dow Jones industrials, are on deck to report quarterly earnings before markets open on Tuesday.
Friday's top analyst upgrades and downgrades included Datadog, DexCom, Exelixis, Lam Research, Las Vegas Sands, Lyft, Match, Nasdaq, Next Era Energy, Norfolk Southern, Pfizer, Walmart and Wolfspeed.
Value stocks are outpacing growth stocks so far this year. These seven outstanding picks come with healthy and dependable dividends and offer slow and steady growth with the ability to weather...